We are live on ! Find out more
TC

TFS Capital Portfolio holdings

AUM $255M
1-Year Est. Return 32.31%
This Fund
S&P 500
This Quarter Est. Return
+5.11%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
10 Year Est. Return
AUM
$544M
AUM Growth
-$150M
Cap. Flow
-$163M
Cap. Flow %
-30.02%
Top 10 Hldgs %
4.42%
Holding
1,403
New
424
Increased
198
Reduced
315
Closed
462

Sector Composition

Rank Sector Weight
1 Healthcare 17.1%
2 Industrials 13.15%
3 Consumer Discretionary 11.75%
4 Technology 11.21%
5 Financials 7.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATYR
901
aTyr Pharma
ATYR
$46.4M
$65K 0.01%
1,675
-174
-9% -$8.09K
VOXX
902
DELISTED
VOXX International Corporation Class A
VOXX
$64K 0.01%
22,857
+4,314
+23% +$16K
BDSI
903
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$62K 0.01%
26,444
-27,268
-51% -$75.2K
GST
904
DELISTED
Gastar Exploration Inc.
GST
$59K 0.01%
53,762
+21,739
+68% +$25.6K
CETV
905
DELISTED
Central European Media Enterprises Ltd
CETV
$58K 0.01%
+27,365
New +$68K
ICAD
906
DELISTED
iCAD Inc
ICAD
$57K 0.01%
+10,966
New +$57.3K
TRQ
907
DELISTED
Turquoise Hill Resources Ltd
TRQ
$55K 0.01%
+1,623
New +$47.1K
LIOX
908
DELISTED
Lionbridge Technologies
LIOX
$55K 0.01%
+13,806
New +$62.1K
ARCO icon
909
Arcos Dorados Holdings
ARCO
$1.73B
$54K 0.01%
11,740
-17,400
-60% -$73.8K
ASPN icon
910
Aspen Aerogels
ASPN
$387M
$53K 0.01%
+10,577
New +$46.3K
NGD
911
DELISTED
New Gold Inc
NGD
$53K 0.01%
12,042
-8,687
-42% -$36.7K
ZVRA icon
912
Zevra Therapeutics
ZVRA
$563M
$53K 0.01%
837
-1,217
-59% -$200K
IMGN
913
DELISTED
Immunogen Inc
IMGN
$52K 0.01%
+17,029
New +$107K
PKD
914
DELISTED
Parker Drilling Company
PKD
$52K 0.01%
1,515
-23,746
-94% -$878K
ANTH
915
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$52K 0.01%
2,108
-12,218
-85% -$345K
NIHD
916
DELISTED
NII Holdings, Inc. Common Stock
NIHD
$52K 0.01%
16,494
+5,211
+46% +$21.9K
AKAO
917
DELISTED
Achaogen Inc
AKAO
$51K 0.01%
+13,587
New +$47.3K
SYUT
918
DELISTED
Synutra International, Inc.
SYUT
$49K 0.01%
+12,785
New +$57.4K
AXTI icon
919
AXT Inc
AXTI
$3.09B
$47K 0.01%
+14,725
New +$45.3K
CCXI
920
DELISTED
ChemoCentryx, Inc.
CCXI
$47K 0.01%
10,386
-46,323
-82% -$174K
CTLP
921
DELISTED
Cantaloupe
CTLP
$45K 0.01%
+10,636
New +$45.6K
NOA
922
North American Construction
NOA
$377M
$45K 0.01%
+15,838
New +$39.3K
BV
923
DELISTED
Bazaarvoice, Inc.
BV
$45K 0.01%
11,183
-486,740
-98% -$1.71M
ACLS icon
924
Axcelis
ACLS
$4.12B
$44K 0.01%
4,082
-142,651
-97% -$1.53M
UTSI icon
925
UTStarcom
UTSI
$22.7M
$40K 0.01%
+5,232
New +$41.1K

Similar funds

TFS Capital's Q2 2016 Portfolio in Review

As of Q2 2016, TFS Capital held 1,403 positions worth $544M, down 22% from $694M the previous quarter. Its ten largest holdings account for 4.4% of the portfolio.

TFS Capital withdrew a net $163M in Q2 2016, closing 462 positions and reducing 315 holdings. Its most notable exit was Insight Enterprises, an estimated $3.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, TFS Capital opened a new position in Hudson Pacific Properties worth $2.77M.

  • TFS Capital's largest Q2 2016 buy was Hudson Pacific Properties: 13,585 shares worth $2.77M.
  • TFS Capital added most to CBL& Associates Properties, Inc. in Q2 2016, an estimated $2.58M increase.
  • TFS Capital's biggest Q2 2016 reduction was Tribune Publishing Company Common Stock, cutting an estimated $2.57M.
  • TFS Capital fully exited Insight Enterprises in Q2 2016, selling an estimated $3.1M.
  • TFS Capital's ten largest holdings make up 4.4% of its $544M portfolio in Q2 2016.
  • TFS Capital opened 424 new positions and closed 462 in Q2 2016.
  • TFS Capital's portfolio value fell 22% quarter-over-quarter to $544M.

Based on TFS Capital's 13F filing for Q2 2016, filed 11 Aug 2016.